Product Highlight - Epotiv
11 Jun 2021
Active ingredient: Recombinant human erythropoietin alpha
Indication: Treatment of anemia of chronic renal failure (CRF) patients
• Symptomatic anemia
• Anemia requiring transfusion
Dosage & Administration: Chronic renal failure patients: Starting dose of Epotiv therapy is 50 U/kg, 3 times per week by slow SC or IV injection over 1~2 minutes. Further dose increase should be determined according to initial response. Dose may be increased by 25 U/kg every four weeks, if needed.
LG CHEM LIFE SCIENCES (THAILAND) LTD.
87/2 CRC Tower, All Seasons Place, 19F, Wireless Rd., Lumpini,
Pathumwan Bangkok 10330 • Tel: (+66) 2654 2275-6 ∙ Fax: (+66) 2654 2277
Indication: Treatment of anemia of chronic renal failure (CRF) patients
• Symptomatic anemia
• Anemia requiring transfusion
Dosage & Administration: Chronic renal failure patients: Starting dose of Epotiv therapy is 50 U/kg, 3 times per week by slow SC or IV injection over 1~2 minutes. Further dose increase should be determined according to initial response. Dose may be increased by 25 U/kg every four weeks, if needed.
LG CHEM LIFE SCIENCES (THAILAND) LTD.
87/2 CRC Tower, All Seasons Place, 19F, Wireless Rd., Lumpini,
Pathumwan Bangkok 10330 • Tel: (+66) 2654 2275-6 ∙ Fax: (+66) 2654 2277
